Congratulations, very nice paper.
-
-
-
Thank you Zeynep!
Kraj razgovora
Novi razgovor -
-
-
Cool work!
-
Thanks!
Kraj razgovora
Novi razgovor -
-
-
Congratulations Mathieu. Looking forward to read it.
-
Thank you Nuria. Always eager to get your perspective on our work.
Kraj razgovora
Novi razgovor -
-
-
Nice Mathieu! Will read with great interest.
-
Thanks Karim. Looking forward to your feedback.
Kraj razgovora
Novi razgovor -
-
-
Congrats - glad to see this work progressing. Those non-coding variants are super interesting. I wonder what the immunophenotype of these are?
-
Depends on whether the immune response against tumours primarily relies on (1) mutant vs (2) wild-type misfolded/modified peptides. Noncoding mutations in regulatory elements are not translated as far as I know. Should only be relevant to option 2. Prob: no good way to test.
- Još 1 odgovor
Novi razgovor -
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.